Abiopharma

🔍 Cinelli Dennis (Executive)

Company: Paramount Skydance Corp (PSKY)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 187,500 shares of Class B common stock (Direct)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 193,594.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2
• Sold 88,974 shares of Class B common stock at $11.67 per share (Direct)
  Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 104,620.00 | transaction_form_type: 4 | Footnotes: F3
• Holds 0 shares of Class B common stock (Direct)
  Date: 2026-04-15 | Code: H | nature_of_ownership: By IRA | shares_owned_after: 28,112.00
• Sold 187,500 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,562,500.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: The shares identified in Table I were issued on April 15, 2026, upon vesting of an installment of Restricted Stock Units ("RSUs") identified in Table II, which were initially granted on January 15, 2026 and generally vest in equal quarterly installments over a five-year period. On April 15, 2026, the closing price of the Class B common stock on The NASDAQ Global Select Market was $11.67 per share.
• F2: Includes shares acquired periodically pursuant to a dividend reinvestment program meeting the requirements of Rule 16a-11.
• F3: These shares were withheld by the Issuer to satisfy tax liability incident to the vesting of, and delivery of shares underlying, the RSUs, and were not actually sold or otherwise disposed of in an open-market transaction.